Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

PARIS, France—In patients with ACS and complex lesions, the incidence of adverse events is lower when OCT rather than angiography is used to guide PCI, according to a subanalysis of the OCCUPI trial.

Please provide your email address to receive an email when new articles are posted on . OCT-guided PCI conferred greater minimal stent area vs. angiography-guided PCI in the CALPISO trial. OCT-guided ...

Please provide your email address to receive an email when new articles are posted on . IVUS-guided PCI reduced risk for target vessel failure for patients with ACS vs. angiography-guided PCI. Lower ...

An “optical biopsy” of intravascular plaque during stenting is more effective at reducing the rate of restenosis or thrombosis in people with moderately or severely calcified lesions than angiography ...

ATLANTA -- The use of intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with acute coronary syndromes resulted in better outcomes compared with ...

Percutaneous coronary intervention (PCI) guided by quantitative flow ratio (QFR) lesion assessment provided better clinical outcomes than visual assessment of the angiogram in the sham-controlled ...

Data regarding clinical outcomes after intravascular imaging–guided percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared with outcomes after angiography-guided PCI ...

A new network analysis adds yet more evidence that PCI performed with angiography alone is inferior to procedures performed either with adjunctive intravascular imaging or invasive functional tests.

There are limited data from randomized trials to guide a specific follow-up surveillance approach after myocardial revascularization. Whether a follow-up strategy that includes routine functional ...

Washington, D.C. – May 1, 2025 – New findings from FAVOR III China Trial, presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific ...

ORLANDO – November 4, 2021 – The FAVOR III China trial found that lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed physiologic measurement quantitative ...